| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.62e-06 | 43 | 13 | 3 | GO:0030280 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 7.43e-08 | 189 | 13 | 5 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.81e-07 | 461 | 13 | 6 | GO:0008544 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 5.62e-07 | 284 | 13 | 5 | GO:0009913 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 5.67e-07 | 27 | 13 | 3 | GO:0018149 | |
| GeneOntologyBiologicalProcess | skin development | 2.15e-06 | 373 | 13 | 5 | GO:0043588 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 1.09e-05 | 71 | 13 | 3 | GO:0045682 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.29e-05 | 75 | 13 | 3 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 2.01e-05 | 87 | 13 | 3 | GO:0031424 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.96e-05 | 99 | 13 | 3 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.05e-05 | 100 | 13 | 3 | GO:0045103 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 4.38e-05 | 16 | 13 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 4.96e-05 | 17 | 13 | 2 | GO:0003334 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.28e-04 | 870 | 13 | 5 | GO:0030855 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 1.69e-04 | 31 | 13 | 2 | GO:0051291 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 1.91e-04 | 33 | 13 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 2.97e-04 | 41 | 13 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | keratinocyte proliferation | 8.64e-04 | 70 | 13 | 2 | GO:0043616 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.44e-03 | 1469 | 13 | 5 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.45e-03 | 91 | 13 | 2 | GO:0006446 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 2.23e-03 | 113 | 13 | 2 | GO:0051262 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 2.55e-03 | 121 | 13 | 2 | GO:0090263 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.89e-03 | 129 | 13 | 2 | GO:0048024 | |
| GeneOntologyBiologicalProcess | translational initiation | 3.03e-03 | 132 | 13 | 2 | GO:0006413 | |
| GeneOntologyCellularComponent | cornified envelope | 7.60e-08 | 69 | 13 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | keratin filament | 2.68e-05 | 97 | 13 | 3 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 3.33e-04 | 227 | 13 | 3 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 5.13e-04 | 263 | 13 | 3 | GO:0045111 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 2.61e-03 | 124 | 13 | 2 | GO:1904813 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.83e-03 | 530 | 13 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 5.70e-03 | 185 | 13 | 2 | GO:0101002 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.95e-03 | 656 | 13 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.01e-03 | 658 | 13 | 3 | GO:0030312 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 6.35e-09 | 4 | 7 | 3 | HP:0007475 | |
| HumanPheno | Palmoplantar keratoderma | 7.91e-06 | 114 | 7 | 4 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 8.19e-06 | 115 | 7 | 4 | HP:0008066 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 8.52e-06 | 33 | 7 | 3 | HP:0007431 | |
| HumanPheno | Palmoplantar hyperkeratosis | 1.30e-05 | 129 | 7 | 4 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 1.38e-05 | 131 | 7 | 4 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 1.42e-05 | 132 | 7 | 4 | HP:0007556 | |
| HumanPheno | Abnormality of the plantar skin of foot | 3.97e-05 | 171 | 7 | 4 | HP:0100872 | |
| HumanPheno | Conjunctival nodule | 8.85e-05 | 11 | 7 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 8.85e-05 | 11 | 7 | 2 | HP:0100780 | |
| HumanPheno | Hyperkeratosis | 1.34e-04 | 233 | 7 | 4 | HP:0000962 | |
| HumanPheno | Abnormality of keratinization | 1.60e-04 | 244 | 7 | 4 | HP:0001035 | |
| HumanPheno | Abnormal epidermal morphology | 2.02e-04 | 94 | 7 | 3 | HP:0011124 | |
| HumanPheno | Regional abnormality of skin | 2.32e-04 | 541 | 7 | 5 | HP:0011356 | |
| HumanPheno | Orthokeratosis | 3.04e-04 | 20 | 7 | 2 | HP:0040162 | |
| HumanPheno | Hypergranulosis | 3.69e-04 | 22 | 7 | 2 | HP:0025114 | |
| HumanPheno | Blistering by anatomical location | 5.18e-04 | 26 | 7 | 2 | HP:0033800 | |
| HumanPheno | Erythema | 5.64e-04 | 133 | 7 | 3 | HP:0010783 | |
| HumanPheno | Skin erosion | 6.02e-04 | 28 | 7 | 2 | HP:0200041 | |
| HumanPheno | Hamartoma of the orbital region | 6.91e-04 | 30 | 7 | 2 | HP:0030670 | |
| HumanPheno | Hamartoma of the eye | 6.91e-04 | 30 | 7 | 2 | HP:0010568 | |
| HumanPheno | Ichthyosis | 7.12e-04 | 144 | 7 | 3 | HP:0008064 | |
| HumanPheno | Epidermal thickening | 8.81e-04 | 379 | 7 | 4 | HP:0011368 | |
| HumanPheno | Fragile skin | 1.05e-03 | 37 | 7 | 2 | HP:0001030 | |
| HumanPheno | Abnormal skin morphology of the palm | 1.22e-03 | 413 | 7 | 4 | HP:0040211 | |
| HumanPheno | Abnormal conjunctiva morphology | 1.28e-03 | 176 | 7 | 3 | HP:0000502 | |
| HumanPheno | Thickened skin | 1.44e-03 | 431 | 7 | 4 | HP:0001072 | |
| MousePheno | hyperkeratosis | 1.10e-06 | 90 | 13 | 4 | MP:0001242 | |
| MousePheno | blistering | 1.26e-06 | 24 | 13 | 3 | MP:0001208 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 5.08e-06 | 132 | 13 | 4 | MP:0001240 | |
| MousePheno | acanthosis | 7.59e-06 | 43 | 13 | 3 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 8.72e-06 | 45 | 13 | 3 | MP:0009611 | |
| MousePheno | scaly skin | 1.60e-05 | 55 | 13 | 3 | MP:0001192 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 2.65e-05 | 65 | 13 | 3 | MP:0001236 | |
| MousePheno | hypergranulosis | 2.86e-05 | 9 | 13 | 2 | MP:0009600 | |
| MousePheno | abnormal skin appearance | 4.46e-05 | 473 | 13 | 5 | MP:0009931 | |
| MousePheno | thick epidermis stratum granulosum | 5.24e-05 | 12 | 13 | 2 | MP:0009599 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 8.33e-05 | 15 | 13 | 2 | MP:0001233 | |
| MousePheno | abnormal epidermal layer morphology | 8.60e-05 | 271 | 13 | 4 | MP:0001216 | |
| MousePheno | abnormal skin physiology | 1.09e-04 | 288 | 13 | 4 | MP:0005501 | |
| MousePheno | abnormal corneocyte morphology | 1.21e-04 | 18 | 13 | 2 | MP:0030605 | |
| MousePheno | abnormal foot pad morphology | 2.56e-04 | 26 | 13 | 2 | MP:0000574 | |
| MousePheno | hyperpigmentation | 2.98e-04 | 28 | 13 | 2 | MP:0001188 | |
| MousePheno | abnormal skin tensile strength | 3.90e-04 | 32 | 13 | 2 | MP:0005275 | |
| MousePheno | small testis | 6.04e-04 | 823 | 13 | 5 | MP:0001147 | |
| MousePheno | increased vascular permeability | 8.07e-04 | 46 | 13 | 2 | MP:0003070 | |
| MousePheno | small gonad | 8.43e-04 | 885 | 13 | 5 | MP:0001116 | |
| MousePheno | abnormal primary sex determination | 9.15e-04 | 901 | 13 | 5 | MP:0002211 | |
| MousePheno | abnormal testis size | 9.82e-04 | 915 | 13 | 5 | MP:0004849 | |
| MousePheno | abnormal heart ventricle wall thickness | 1.07e-03 | 227 | 13 | 3 | MP:0020135 | |
| MousePheno | abnormal sex determination | 1.14e-03 | 945 | 13 | 5 | MP:0002210 | |
| MousePheno | decreased circulating serum albumin level | 1.23e-03 | 238 | 13 | 3 | MP:0005419 | |
| MousePheno | impaired skin barrier function | 1.56e-03 | 64 | 13 | 2 | MP:0002796 | |
| MousePheno | epidermal hyperplasia | 1.71e-03 | 67 | 13 | 2 | MP:0001222 | |
| MousePheno | abnormal vascular permeability | 1.76e-03 | 68 | 13 | 2 | MP:0001619 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 1.86e-03 | 70 | 13 | 2 | MP:0001239 | |
| MousePheno | abnormal testis morphology | 2.08e-03 | 1081 | 13 | 5 | MP:0001146 | |
| MousePheno | abnormal heart ventricle wall morphology | 2.30e-03 | 296 | 13 | 3 | MP:0031532 | |
| MousePheno | thick epidermis | 2.42e-03 | 80 | 13 | 2 | MP:0001219 | |
| MousePheno | abnormal skin pigmentation | 2.86e-03 | 87 | 13 | 2 | MP:0002095 | |
| MousePheno | abnormal circulating serum albumin level | 3.29e-03 | 336 | 13 | 3 | MP:0000199 | |
| Domain | Intermediate_filament_CS | 1.02e-05 | 63 | 13 | 3 | IPR018039 | |
| Domain | Filament | 1.47e-05 | 71 | 13 | 3 | SM01391 | |
| Domain | IF | 1.53e-05 | 72 | 13 | 3 | PS00226 | |
| Domain | Filament | 1.59e-05 | 73 | 13 | 3 | PF00038 | |
| Domain | IF | 1.80e-05 | 76 | 13 | 3 | IPR001664 | |
| Domain | Keratin_2_head | 1.22e-04 | 24 | 13 | 2 | PF16208 | |
| Domain | Keratin_2_head | 1.22e-04 | 24 | 13 | 2 | IPR032444 | |
| Domain | Keratin_II | 1.44e-04 | 26 | 13 | 2 | IPR003054 | |
| Domain | RRM_1 | 3.59e-04 | 208 | 13 | 3 | PF00076 | |
| Domain | RRM | 4.06e-04 | 217 | 13 | 3 | SM00360 | |
| Domain | Keratin_I | 4.16e-04 | 44 | 13 | 2 | IPR002957 | |
| Domain | RRM_dom | 4.63e-04 | 227 | 13 | 3 | IPR000504 | |
| Domain | RRM | 4.81e-04 | 230 | 13 | 3 | PS50102 | |
| Domain | - | 5.72e-04 | 244 | 13 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 6.73e-04 | 258 | 13 | 3 | IPR012677 | |
| Domain | Prefoldin | 1.11e-03 | 72 | 13 | 2 | IPR009053 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.61e-05 | 87 | 11 | 3 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.17e-04 | 129 | 11 | 3 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 1.94e-04 | 153 | 11 | 3 | MM15343 | |
| Pathway | WP_MRNA_PROCESSING | 2.85e-04 | 451 | 11 | 4 | MM15946 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 4.25e-04 | 40 | 11 | 2 | M48231 | |
| Pathway | REACTOME_KERATINIZATION | 5.42e-04 | 217 | 11 | 3 | M27640 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 5.22e-03 | 478 | 11 | 3 | M27620 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.98e-03 | 502 | 11 | 3 | MM14537 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 6.29e-03 | 511 | 11 | 3 | MM15330 | |
| Pubmed | 4.08e-11 | 3 | 13 | 3 | 26581228 | ||
| Pubmed | 4.53e-11 | 19 | 13 | 4 | 35173535 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 7.00e-11 | 21 | 13 | 4 | 33029523 | |
| Pubmed | 1.24e-10 | 24 | 13 | 4 | 27507811 | ||
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 1.39e-10 | 91 | 13 | 5 | 34445801 | |
| Pubmed | 1.63e-10 | 4 | 13 | 3 | 32179842 | ||
| Pubmed | 4.80e-10 | 286 | 13 | 6 | 32041737 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 1.03e-09 | 135 | 13 | 5 | 29859926 | |
| Pubmed | 1.13e-09 | 330 | 13 | 6 | 32529326 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.69e-09 | 353 | 13 | 6 | 27545878 | |
| Pubmed | 1.73e-09 | 45 | 13 | 4 | 30619335 | ||
| Pubmed | 2.28e-09 | 8 | 13 | 3 | 7543090 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 3.18e-09 | 169 | 13 | 5 | 23084401 | |
| Pubmed | 3.67e-09 | 54 | 13 | 4 | 35474131 | ||
| Pubmed | 6.87e-09 | 197 | 13 | 5 | 23686814 | ||
| Pubmed | 1.16e-08 | 13 | 13 | 3 | 8999895 | ||
| Pubmed | 1.40e-08 | 75 | 13 | 4 | 31527668 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 2.23e-08 | 84 | 13 | 4 | 29563501 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 2.59e-08 | 558 | 13 | 6 | 27591049 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 4.14e-08 | 604 | 13 | 6 | 37616343 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.18e-08 | 605 | 13 | 6 | 28977666 | |
| Pubmed | 4.66e-08 | 289 | 13 | 5 | 37132043 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 5.12e-08 | 626 | 13 | 6 | 33644029 | |
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 5.40e-08 | 21 | 13 | 3 | 17373842 | |
| Pubmed | 5.43e-08 | 298 | 13 | 5 | 30737378 | ||
| Pubmed | 6.23e-08 | 1153 | 13 | 7 | 29845934 | ||
| Pubmed | 8.22e-08 | 24 | 13 | 3 | 30719818 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 1.02e-07 | 704 | 13 | 6 | 32994395 | |
| Pubmed | 1.06e-07 | 26 | 13 | 3 | 15454262 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.12e-07 | 1257 | 13 | 7 | 36526897 | |
| Pubmed | 1.14e-07 | 346 | 13 | 5 | 25324306 | ||
| Pubmed | Out of balance: consequences of a partial keratin 10 knockout. | 1.29e-07 | 2 | 13 | 2 | 9378767 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 1380247 | ||
| Pubmed | Keratins K2 and K10 are essential for the epidermal integrity of plantar skin. | 1.29e-07 | 2 | 13 | 2 | 26603179 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 11531804 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 31036554 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 23182068 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 34199056 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 21271994 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 27421141 | ||
| Pubmed | Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation. | 1.29e-07 | 2 | 13 | 2 | 24751727 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 27722766 | ||
| Pubmed | Chromosomal mapping of human keratin genes: evidence of non-linkage. | 1.29e-07 | 2 | 13 | 2 | 2461420 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 22375063 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 35623459 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 27595935 | ||
| Pubmed | Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma. | 1.29e-07 | 2 | 13 | 2 | 30021014 | |
| Pubmed | Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. | 1.29e-07 | 2 | 13 | 2 | 1380725 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 1379726 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 7507152 | ||
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 7512983 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 2.91e-07 | 418 | 13 | 5 | 32552912 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.98e-07 | 420 | 13 | 5 | 28065597 | |
| Pubmed | 3.02e-07 | 421 | 13 | 5 | 34650049 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 3.35e-07 | 430 | 13 | 5 | 38172120 | |
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 8603923 | ||
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 18637039 | ||
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 7509717 | ||
| Pubmed | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. | 4.00e-07 | 40 | 13 | 3 | 21151833 | |
| Pubmed | 4.24e-07 | 451 | 13 | 5 | 36168627 | ||
| Pubmed | 4.31e-07 | 41 | 13 | 3 | 34638806 | ||
| Pubmed | 5.57e-07 | 187 | 13 | 4 | 29777862 | ||
| Pubmed | 6.14e-07 | 46 | 13 | 3 | 36147463 | ||
| Pubmed | 7.74e-07 | 4 | 13 | 2 | 7679677 | ||
| Pubmed | Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes. | 7.74e-07 | 4 | 13 | 2 | 36077435 | |
| Pubmed | Complete Structure of an Epithelial Keratin Dimer: Implications for Intermediate Filament Assembly. | 7.74e-07 | 4 | 13 | 2 | 26181054 | |
| Pubmed | 8.41e-07 | 51 | 13 | 3 | 36896912 | ||
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 1.03e-06 | 218 | 13 | 4 | 35831895 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.14e-06 | 224 | 13 | 4 | 28443643 | |
| Pubmed | 1.18e-06 | 57 | 13 | 3 | 31862882 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.27e-06 | 1082 | 13 | 6 | 38697112 | |
| Pubmed | 1.29e-06 | 5 | 13 | 2 | 2458356 | ||
| Pubmed | 1.29e-06 | 5 | 13 | 2 | 33779546 | ||
| Pubmed | 1.38e-06 | 60 | 13 | 3 | 31220272 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.46e-06 | 238 | 13 | 4 | 35864588 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.46e-06 | 580 | 13 | 5 | 35676659 | |
| Pubmed | 1.52e-06 | 62 | 13 | 3 | 26644517 | ||
| Pubmed | 1.60e-06 | 63 | 13 | 3 | 16831889 | ||
| Pubmed | 1.63e-06 | 245 | 13 | 4 | 35652658 | ||
| Pubmed | 1.76e-06 | 65 | 13 | 3 | 29795372 | ||
| Pubmed | 1.93e-06 | 6 | 13 | 2 | 7525178 | ||
| Pubmed | Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. | 1.93e-06 | 6 | 13 | 2 | 22135020 | |
| Pubmed | Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | 1.93e-06 | 6 | 13 | 2 | 14638864 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.95e-06 | 256 | 13 | 4 | 32698014 | |
| Pubmed | 2.27e-06 | 266 | 13 | 4 | 19380743 | ||
| Pubmed | 2.38e-06 | 641 | 13 | 5 | 36057605 | ||
| Pubmed | 2.50e-06 | 73 | 13 | 3 | 35973989 | ||
| Pubmed | Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation. | 2.71e-06 | 7 | 13 | 2 | 16837463 | |
| Pubmed | Regulation of epidermal differentiation by a Distal-less homeodomain gene. | 2.71e-06 | 7 | 13 | 2 | 8991098 | |
| Pubmed | 2.71e-06 | 7 | 13 | 2 | 10191051 | ||
| Pubmed | 2.82e-06 | 281 | 13 | 4 | 26725010 | ||
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 3.06e-06 | 287 | 13 | 4 | 36180891 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.14e-06 | 678 | 13 | 5 | 30209976 | |
| Pubmed | 3.61e-06 | 8 | 13 | 2 | 19515043 | ||
| Pubmed | Calmodulin 4 is dispensable for epidermal barrier formation and wound healing in mice. | 3.61e-06 | 8 | 13 | 2 | 25316000 | |
| Pubmed | Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8. | 3.61e-06 | 8 | 13 | 2 | 24449888 | |
| Pubmed | 3.85e-06 | 707 | 13 | 5 | 19738201 | ||
| Pubmed | 14-3-3sigma controls mitotic translation to facilitate cytokinesis. | 4.10e-06 | 86 | 13 | 3 | 17361185 | |
| Pubmed | 4.35e-06 | 725 | 13 | 5 | 27025967 | ||
| Pubmed | Aurora kinase-A deficiency during skin development impairs cell division and stratification. | 4.64e-06 | 9 | 13 | 2 | 22832491 | |
| Interaction | EFNA1 interactions | 3.94e-09 | 103 | 13 | 5 | int:EFNA1 | |
| Interaction | KRT17 interactions | 5.74e-09 | 252 | 13 | 6 | int:KRT17 | |
| Interaction | DIRAS2 interactions | 2.77e-08 | 52 | 13 | 4 | int:DIRAS2 | |
| Interaction | FBP1 interactions | 3.93e-08 | 348 | 13 | 6 | int:FBP1 | |
| Interaction | NDN interactions | 1.87e-07 | 453 | 13 | 6 | int:NDN | |
| Interaction | KRT77 interactions | 3.34e-07 | 96 | 13 | 4 | int:KRT77 | |
| Interaction | MAGOH interactions | 4.39e-07 | 264 | 13 | 5 | int:MAGOH | |
| Interaction | EFNA3 interactions | 5.37e-07 | 108 | 13 | 4 | int:EFNA3 | |
| Interaction | METTL3 interactions | 6.63e-07 | 287 | 13 | 5 | int:METTL3 | |
| Interaction | CUL2 interactions | 8.93e-07 | 591 | 13 | 6 | int:CUL2 | |
| Interaction | PIGR interactions | 1.24e-06 | 133 | 13 | 4 | int:PIGR | |
| Interaction | MIDN interactions | 1.25e-06 | 626 | 13 | 6 | int:MIDN | |
| Interaction | TNF interactions | 1.53e-06 | 340 | 13 | 5 | int:TNF | |
| Interaction | ARL4D interactions | 1.80e-06 | 146 | 13 | 4 | int:ARL4D | |
| Interaction | LARP7 interactions | 1.97e-06 | 1113 | 13 | 7 | int:LARP7 | |
| Interaction | NPHP3 interactions | 2.37e-06 | 42 | 13 | 3 | int:NPHP3 | |
| Interaction | RLIM interactions | 3.07e-06 | 392 | 13 | 5 | int:RLIM | |
| Interaction | RNF31 interactions | 3.52e-06 | 403 | 13 | 5 | int:RNF31 | |
| Interaction | ZUP1 interactions | 3.61e-06 | 174 | 13 | 4 | int:ZUP1 | |
| Interaction | CHD3 interactions | 3.77e-06 | 757 | 13 | 6 | int:CHD3 | |
| Interaction | KRT10 interactions | 4.81e-06 | 187 | 13 | 4 | int:KRT10 | |
| Interaction | BTF3 interactions | 5.15e-06 | 799 | 13 | 6 | int:BTF3 | |
| Interaction | KRT5 interactions | 5.45e-06 | 193 | 13 | 4 | int:KRT5 | |
| Interaction | WTAP interactions | 5.56e-06 | 194 | 13 | 4 | int:WTAP | |
| Interaction | SMAD3 interactions | 5.83e-06 | 447 | 13 | 5 | int:SMAD3 | |
| Interaction | KRT16 interactions | 5.91e-06 | 197 | 13 | 4 | int:KRT16 | |
| Interaction | TRIM31 interactions | 6.29e-06 | 454 | 13 | 5 | int:TRIM31 | |
| Interaction | PRPH interactions | 6.79e-06 | 204 | 13 | 4 | int:PRPH | |
| Interaction | RIN3 interactions | 6.92e-06 | 463 | 13 | 5 | int:RIN3 | |
| Interaction | MEPCE interactions | 7.82e-06 | 859 | 13 | 6 | int:MEPCE | |
| Interaction | INPPL1 interactions | 8.20e-06 | 214 | 13 | 4 | int:INPPL1 | |
| Interaction | CYLD interactions | 8.30e-06 | 868 | 13 | 6 | int:CYLD | |
| Interaction | ARHGAP24 interactions | 8.76e-06 | 486 | 13 | 5 | int:ARHGAP24 | |
| Interaction | EIF4A3 interactions | 9.96e-06 | 499 | 13 | 5 | int:EIF4A3 | |
| Interaction | PIK3R2 interactions | 1.09e-05 | 230 | 13 | 4 | int:PIK3R2 | |
| Interaction | ARF5 interactions | 1.11e-05 | 231 | 13 | 4 | int:ARF5 | |
| Interaction | HEXIM1 interactions | 1.11e-05 | 913 | 13 | 6 | int:HEXIM1 | |
| Interaction | KRT2 interactions | 1.21e-05 | 236 | 13 | 4 | int:KRT2 | |
| Interaction | KRT1 interactions | 1.25e-05 | 238 | 13 | 4 | int:KRT1 | |
| Interaction | MINDY4 interactions | 1.27e-05 | 73 | 13 | 3 | int:MINDY4 | |
| Interaction | PRSS1 interactions | 1.27e-05 | 73 | 13 | 3 | int:PRSS1 | |
| Interaction | CHD4 interactions | 1.30e-05 | 938 | 13 | 6 | int:CHD4 | |
| Interaction | HNRNPA1 interactions | 1.35e-05 | 945 | 13 | 6 | int:HNRNPA1 | |
| Interaction | RNF208 interactions | 1.38e-05 | 75 | 13 | 3 | int:RNF208 | |
| Interaction | OGT interactions | 1.39e-05 | 950 | 13 | 6 | int:OGT | |
| Interaction | PAGE4 interactions | 1.59e-05 | 253 | 13 | 4 | int:PAGE4 | |
| Interaction | KRT7 interactions | 1.67e-05 | 80 | 13 | 3 | int:KRT7 | |
| Interaction | METTL14 interactions | 1.71e-05 | 558 | 13 | 5 | int:METTL14 | |
| Interaction | RPS6KB2 interactions | 1.79e-05 | 261 | 13 | 4 | int:RPS6KB2 | |
| Interaction | AHI1 interactions | 1.87e-05 | 83 | 13 | 3 | int:AHI1 | |
| Interaction | ARL16 interactions | 1.87e-05 | 83 | 13 | 3 | int:ARL16 | |
| Interaction | DCUN1D1 interactions | 2.20e-05 | 275 | 13 | 4 | int:DCUN1D1 | |
| Interaction | DDX24 interactions | 2.35e-05 | 596 | 13 | 5 | int:DDX24 | |
| Interaction | EIF3F interactions | 2.94e-05 | 296 | 13 | 4 | int:EIF3F | |
| Interaction | INVS interactions | 3.17e-05 | 99 | 13 | 3 | int:INVS | |
| Interaction | COPS5 interactions | 3.25e-05 | 1102 | 13 | 6 | int:COPS5 | |
| Interaction | ACE2 interactions | 3.31e-05 | 1106 | 13 | 6 | int:ACE2 | |
| Interaction | CFAP57 interactions | 3.48e-05 | 14 | 13 | 2 | int:CFAP57 | |
| Interaction | DDX3X interactions | 3.59e-05 | 651 | 13 | 5 | int:DDX3X | |
| Interaction | ARIH2 interactions | 3.70e-05 | 314 | 13 | 4 | int:ARIH2 | |
| Interaction | FBXL4 interactions | 3.89e-05 | 106 | 13 | 3 | int:FBXL4 | |
| Interaction | EVPL interactions | 3.89e-05 | 106 | 13 | 3 | int:EVPL | |
| Interaction | RC3H2 interactions | 4.04e-05 | 667 | 13 | 5 | int:RC3H2 | |
| Interaction | RC3H1 interactions | 4.33e-05 | 677 | 13 | 5 | int:RC3H1 | |
| Interaction | EEF1D interactions | 4.65e-05 | 333 | 13 | 4 | int:EEF1D | |
| Interaction | FAF1 interactions | 4.71e-05 | 334 | 13 | 4 | int:FAF1 | |
| Interaction | KRT13 interactions | 5.10e-05 | 116 | 13 | 3 | int:KRT13 | |
| Interaction | CUL4B interactions | 6.13e-05 | 728 | 13 | 5 | int:CUL4B | |
| Interaction | IQCB1 interactions | 7.01e-05 | 370 | 13 | 4 | int:IQCB1 | |
| Interaction | CRK interactions | 7.01e-05 | 370 | 13 | 4 | int:CRK | |
| Interaction | NPHP1 interactions | 7.15e-05 | 130 | 13 | 3 | int:NPHP1 | |
| Interaction | ARAF interactions | 7.46e-05 | 376 | 13 | 4 | int:ARAF | |
| Interaction | MECP2 interactions | 7.79e-05 | 1287 | 13 | 6 | int:MECP2 | |
| Interaction | MKS1 interactions | 8.73e-05 | 139 | 13 | 3 | int:MKS1 | |
| Interaction | NEDD8 interactions | 8.86e-05 | 393 | 13 | 4 | int:NEDD8 | |
| Interaction | PAN2 interactions | 9.21e-05 | 397 | 13 | 4 | int:PAN2 | |
| Interaction | COPS6 interactions | 1.02e-04 | 408 | 13 | 4 | int:COPS6 | |
| Interaction | MYCN interactions | 1.12e-04 | 1373 | 13 | 6 | int:MYCN | |
| Interaction | KRT18 interactions | 1.13e-04 | 419 | 13 | 4 | int:KRT18 | |
| Interaction | RNF8 interactions | 1.16e-04 | 421 | 13 | 4 | int:RNF8 | |
| Interaction | DSP interactions | 1.18e-04 | 423 | 13 | 4 | int:DSP | |
| Interaction | UBASH3B interactions | 1.25e-04 | 157 | 13 | 3 | int:UBASH3B | |
| Interaction | AP2M1 interactions | 1.25e-04 | 430 | 13 | 4 | int:AP2M1 | |
| Interaction | FN1 interactions | 1.26e-04 | 848 | 13 | 5 | int:FN1 | |
| Interaction | DES interactions | 1.28e-04 | 158 | 13 | 3 | int:DES | |
| Interaction | KRT6A interactions | 1.32e-04 | 160 | 13 | 3 | int:KRT6A | |
| Interaction | HDAC2 interactions | 1.39e-04 | 865 | 13 | 5 | int:HDAC2 | |
| Interaction | ASXL3 interactions | 1.45e-04 | 165 | 13 | 3 | int:ASXL3 | |
| Interaction | CUL1 interactions | 1.47e-04 | 876 | 13 | 5 | int:CUL1 | |
| Interaction | CAND1 interactions | 1.62e-04 | 894 | 13 | 5 | int:CAND1 | |
| Interaction | KRT28 interactions | 1.65e-04 | 30 | 13 | 2 | int:KRT28 | |
| Interaction | TRAF6 interactions | 1.70e-04 | 465 | 13 | 4 | int:TRAF6 | |
| Interaction | EWSR1 interactions | 1.73e-04 | 906 | 13 | 5 | int:EWSR1 | |
| Interaction | VCAM1 interactions | 1.84e-04 | 475 | 13 | 4 | int:VCAM1 | |
| Interaction | KRT75 interactions | 1.91e-04 | 181 | 13 | 3 | int:KRT75 | |
| Interaction | HDAC6 interactions | 1.94e-04 | 929 | 13 | 5 | int:HDAC6 | |
| Interaction | THRB interactions | 2.07e-04 | 186 | 13 | 3 | int:THRB | |
| Interaction | ARL10 interactions | 2.17e-04 | 189 | 13 | 3 | int:ARL10 | |
| Interaction | TNIP2 interactions | 2.18e-04 | 952 | 13 | 5 | int:TNIP2 | |
| Interaction | KRT25 interactions | 2.26e-04 | 35 | 13 | 2 | int:KRT25 | |
| Cytoband | 12q13.13 | 1.62e-04 | 67 | 13 | 2 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 6.18e-03 | 423 | 13 | 2 | chr12q13 | |
| GeneFamily | Keratins, type II | 1.17e-04 | 27 | 11 | 2 | 609 | |
| GeneFamily | RNA binding motif containing | 2.48e-04 | 213 | 11 | 3 | 725 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 2.38e-05 | 15 | 13 | 2 | M13308 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 4.29e-05 | 20 | 13 | 2 | M17175 | |
| Coexpression | AZARE_STAT3_TARGETS | 6.23e-05 | 24 | 13 | 2 | M2312 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 7.70e-05 | 173 | 13 | 3 | M650 | |
| Coexpression | GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP | 9.54e-05 | 186 | 13 | 3 | M9228 | |
| Coexpression | GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN | 1.17e-04 | 199 | 13 | 3 | M7183 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 1.17e-04 | 199 | 13 | 3 | M7656 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 1.18e-04 | 200 | 13 | 3 | M8212 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.18e-04 | 200 | 13 | 3 | M328 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.25e-04 | 204 | 13 | 3 | MM966 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 1.98e-04 | 238 | 13 | 3 | M2020 | |
| Coexpression | JAEGER_METASTASIS_DN | 2.56e-04 | 260 | 13 | 3 | M10702 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 2.59e-04 | 261 | 13 | 3 | MM1277 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 2.64e-04 | 49 | 13 | 2 | MM452 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 3.15e-04 | 279 | 13 | 3 | M2246 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 3.64e-04 | 293 | 13 | 3 | MM895 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 3.80e-04 | 1394 | 13 | 5 | M9585 | |
| Coexpression | GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 | 4.36e-04 | 63 | 13 | 2 | M18201 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 8.68e-05 | 451 | 12 | 4 | GSM538280_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 8.72e-05 | 25 | 12 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | skin | 9.06e-05 | 456 | 12 | 4 | skin | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.57e-07 | 199 | 13 | 4 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.63e-07 | 200 | 13 | 4 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.63e-07 | 200 | 13 | 4 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 185 | 13 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.96e-05 | 187 | 13 | 3 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.06e-05 | 190 | 13 | 3 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.06e-05 | 190 | 13 | 3 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.06e-05 | 190 | 13 | 3 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Fos_(Deep_layer_pyramidal_cells_(IEG))|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 67 | 13 | 2 | b17d498034ab8280be4991cca1527373d7e43f38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.04e-04 | 90 | 13 | 2 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-A|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.71e-04 | 112 | 13 | 2 | d21cfcb04a27cc9fb74e0c2afa8a8cdfb886ae21 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.49e-04 | 121 | 13 | 2 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 130 | 13 | 2 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.33e-04 | 130 | 13 | 2 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-04 | 131 | 13 | 2 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-04 | 136 | 13 | 2 | 94eb78a4b8da307c07c2c4f05b8a14424f887579 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-04 | 139 | 13 | 2 | da8874d441b8e69c94bad771635f378ddafb49fe | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.75e-04 | 144 | 13 | 2 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-04 | 149 | 13 | 2 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | PSB-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.74e-04 | 153 | 13 | 2 | 4d45aa5e3710d5badc13940f14095c1894dbab9d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-04 | 158 | 13 | 2 | 0c3907e3395ed01b3fd7b75fdca6feadc890ea85 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.67e-04 | 161 | 13 | 2 | a3318e738836eb1c5babe1a5d2dd7fa34d732662 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 166 | 13 | 2 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-late_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-03 | 166 | 13 | 2 | b4e5466a33578103d197cf67f37e7ec88e09281f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 167 | 13 | 2 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.05e-03 | 168 | 13 | 2 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 169 | 13 | 2 | 7be742160e3e7e6c8f86b037be4e425f4d4cf663 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 169 | 13 | 2 | 4ccf5cfa4fe72d3af056d658460a9ccaa07b01be | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.09e-03 | 171 | 13 | 2 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 172 | 13 | 2 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.10e-03 | 172 | 13 | 2 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.10e-03 | 172 | 13 | 2 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-03 | 172 | 13 | 2 | f0b658baa4b41329c95a09387cc55ea046e2333f | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 173 | 13 | 2 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-03 | 173 | 13 | 2 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.13e-03 | 174 | 13 | 2 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 175 | 13 | 2 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-03 | 175 | 13 | 2 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 175 | 13 | 2 | b4ff5a74ad22addbdd848dde9ba93d63a0611543 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 175 | 13 | 2 | 27a8c6e398638ccdee90c44e2ca6f59acc206cbc | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 4880fa20b50eb10358e08567e08559ef2954f237 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | fcdddd949ca05b3ecde240db9e38296a6eab2d6a | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 1.15e-03 | 176 | 13 | 2 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.15e-03 | 176 | 13 | 2 | 9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 4d2fb51e71bed0d72f3d7f89d395744860885a5f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 177 | 13 | 2 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 177 | 13 | 2 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-03 | 178 | 13 | 2 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 178 | 13 | 2 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.19e-03 | 179 | 13 | 2 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 179 | 13 | 2 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 180 | 13 | 2 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-03 | 180 | 13 | 2 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 180 | 13 | 2 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 181 | 13 | 2 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 181 | 13 | 2 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 181 | 13 | 2 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 182 | 13 | 2 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-03 | 183 | 13 | 2 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-03 | 183 | 13 | 2 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-03 | 184 | 13 | 2 | 97e97de52daaff8840f4ee76a94ba5e3f79de7ce | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 184 | 13 | 2 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.26e-03 | 184 | 13 | 2 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-03 | 184 | 13 | 2 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-03 | 185 | 13 | 2 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-03 | 185 | 13 | 2 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 186 | 13 | 2 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | IIF-Other-RBC|IIF / Disease, Lineage and Cell Type | 1.29e-03 | 186 | 13 | 2 | db3c3fc2045c657b300b640bf228640c30782509 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-03 | 186 | 13 | 2 | 0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-03 | 186 | 13 | 2 | 2cbf1aaff87cd9fba01f814a119fe86e5af82290 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 186 | 13 | 2 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-03 | 186 | 13 | 2 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-03 | 187 | 13 | 2 | 13023661c26aaf9e42262a4ff91f2fb26e8a3eaf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-03 | 187 | 13 | 2 | c4ba9dfedbcf0357a8627af03f4fe1770e985a03 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-03 | 188 | 13 | 2 | da211e7fb62fff176aa9c39061aef9ab0af6079e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-03 | 188 | 13 | 2 | 986aaf31161ec3d1e6c76ee2dd17f44848a21f7e | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.31e-03 | 188 | 13 | 2 | b294d6658e79328bd6fa33223e8c70117ba9789b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-03 | 188 | 13 | 2 | 3467149de45b47a5015486ef94bec070e9c3ffc2 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.31e-03 | 188 | 13 | 2 | b9c5d573fc5ab0f7f38c55d006f9576634b05462 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-03 | 188 | 13 | 2 | 3c6c0eaadc474ebb218ae349b787c410f66177ab | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 189 | 13 | 2 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-03 | 189 | 13 | 2 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.34e-03 | 190 | 13 | 2 | 9a2244c3973aee7270646bf00db7727edb9decc5 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.34e-03 | 190 | 13 | 2 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.34e-03 | 190 | 13 | 2 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 191 | 13 | 2 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-03 | 191 | 13 | 2 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 191 | 13 | 2 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-03 | 192 | 13 | 2 | ac3d87aa301d30515c369bd7fc16f33b82173a85 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.37e-03 | 192 | 13 | 2 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.37e-03 | 192 | 13 | 2 | f68e6cbde87678122da1b5c0061904cfb7d04bf5 | |
| ToppCell | facs-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 192 | 13 | 2 | 1f81b356520b5506051383d37fae204d59795336 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.38e-03 | 193 | 13 | 2 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-03 | 193 | 13 | 2 | 72d20ee257149b238016b44d183ce3fc24b8f621 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-03 | 193 | 13 | 2 | 2661ad9107ed9231e4afea4442a79051139a31df | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-03 | 193 | 13 | 2 | f7e4a390921780587b9bd084e495e646fa1ec74f | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-03 | 193 | 13 | 2 | 72128ece598070f8e752a0691e024e26ab364989 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.38e-03 | 193 | 13 | 2 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| Computational | Neighborhood of DDX5 | 1.57e-05 | 63 | 9 | 3 | GNF2_DDX5 | |
| Computational | Keratin. | 2.00e-04 | 26 | 9 | 2 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 2.00e-04 | 26 | 9 | 2 | MODULE_68 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.48e-04 | 50 | 9 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes in the cancer module 322. | 1.04e-03 | 59 | 9 | 2 | MODULE_322 | |
| Computational | Intermediate filaments. | 1.68e-03 | 75 | 9 | 2 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 1.90e-03 | 80 | 9 | 2 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 1.90e-03 | 80 | 9 | 2 | MODULE_357 | |
| Drug | beta-damascenone | 2.92e-07 | 24 | 13 | 3 | ctd:C075388 | |
| Drug | CH2Cl | 4.72e-07 | 28 | 13 | 3 | CID005378701 | |
| Drug | AC1L9MJT | 3.30e-06 | 192 | 13 | 4 | CID000448959 | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.73e-06 | 198 | 13 | 4 | 2725_UP | |
| Drug | Chromates | 1.08e-05 | 9 | 13 | 2 | ctd:D002840 | |
| Drug | AC1O517G | 3.60e-05 | 16 | 13 | 2 | CID006450188 | |
| Drug | K-11 | 4.07e-05 | 17 | 13 | 2 | CID000469667 | |
| Drug | teleocidin B | 4.23e-05 | 123 | 13 | 3 | CID000072425 | |
| Drug | dithranol | 4.58e-05 | 18 | 13 | 2 | CID000002202 | |
| Drug | bromovanin | 4.65e-05 | 127 | 13 | 3 | ctd:C515564 | |
| Drug | sulfur mustard | 4.99e-05 | 130 | 13 | 3 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.10e-05 | 131 | 13 | 3 | CID000107712 | |
| Drug | dichloromethyl | 5.68e-05 | 20 | 13 | 2 | CID000123193 | |
| Drug | disoxaril | 7.56e-05 | 23 | 13 | 2 | CID000055717 | |
| Drug | al-Badry | 1.01e-04 | 165 | 13 | 3 | CID000004545 | |
| Drug | Bi-E | 1.05e-04 | 27 | 13 | 2 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 1.13e-04 | 28 | 13 | 2 | CID011650719 | |
| Drug | AC1NQZM2 | 1.21e-04 | 29 | 13 | 2 | CID005282177 | |
| Drug | K-13 | 1.39e-04 | 31 | 13 | 2 | CID000469669 | |
| Drug | GW0742 | 1.39e-04 | 31 | 13 | 2 | ctd:C479979 | |
| Drug | mucidin | 1.48e-04 | 32 | 13 | 2 | CID006437379 | |
| Drug | AC1NBTRA | 1.48e-04 | 32 | 13 | 2 | CID004473609 | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 1.66e-04 | 195 | 13 | 3 | 449_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.66e-04 | 195 | 13 | 3 | 5115_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 2670_UP | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 1.71e-04 | 197 | 13 | 3 | 371_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.74e-04 | 198 | 13 | 3 | 4316_UP | |
| Drug | tazarotene | 2.32e-04 | 40 | 13 | 2 | CID000005381 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 2.81e-04 | 44 | 13 | 2 | ctd:C419410 | |
| Drug | D-glucamine | 2.94e-04 | 45 | 13 | 2 | CID000027282 | |
| Drug | d-indobufen | 3.63e-04 | 50 | 13 | 2 | CID000044562 | |
| Drug | CKI-7 | 4.08e-04 | 53 | 13 | 2 | CID000129236 | |
| Drug | cignolin | 4.55e-04 | 56 | 13 | 2 | CID000010187 | |
| Drug | AC1L9INI | 5.06e-04 | 59 | 13 | 2 | CID000445839 | |
| Drug | 1-2q | 5.27e-04 | 289 | 13 | 3 | CID000011820 | |
| Drug | TG-2 | 5.76e-04 | 63 | 13 | 2 | CID000574319 | |
| Drug | alitretinoin | 5.93e-04 | 301 | 13 | 3 | ctd:C103303 | |
| Drug | 9-cis-acitretin | 7.31e-04 | 71 | 13 | 2 | CID000041317 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 7.73e-04 | 73 | 13 | 2 | CID011963505 | |
| Drug | 4-oxoretinoic acid | 8.60e-04 | 77 | 13 | 2 | CID006437063 | |
| Drug | 1pxm | 8.82e-04 | 78 | 13 | 2 | CID000447959 | |
| Drug | fullerene C60 | 1.01e-03 | 1498 | 13 | 5 | ctd:C069837 | |
| Drug | Velcade (bortezomib | 1.11e-03 | 374 | 13 | 3 | CID000093860 | |
| Drug | 4-hydroxyproline | 1.20e-03 | 91 | 13 | 2 | CID000000825 | |
| Drug | AC1MHEDK | 1.28e-03 | 94 | 13 | 2 | CID003002889 | |
| Drug | AC1L1GT5 | 1.30e-03 | 95 | 13 | 2 | CID000003829 | |
| Drug | microcystin RR | 1.33e-03 | 96 | 13 | 2 | ctd:C063855 | |
| Drug | adenosine 3',5'-cyclic phosphate | 1.34e-03 | 907 | 13 | 4 | CID000000274 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 1.52e-07 | 2 | 12 | 2 | C3665704 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 1.52e-07 | 2 | 12 | 2 | C1843463 | |
| Disease | Epidermolytic ichthyosis | 1.52e-07 | 2 | 12 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 1.52e-07 | 2 | 12 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 1.52e-07 | 2 | 12 | 2 | cv:C1843463 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 1.52e-07 | 2 | 12 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 1.52e-07 | 2 | 12 | 2 | EFO_0021839 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 4.55e-07 | 3 | 12 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Hyperkeratosis, Epidermolytic | 1.52e-06 | 5 | 12 | 2 | C0079153 | |
| Disease | Keratoderma, Palmoplantar | 1.81e-05 | 16 | 12 | 2 | C4551675 | |
| Disease | Malignant neoplasm of skin | 2.56e-04 | 59 | 12 | 2 | C0007114 | |
| Disease | Skin Neoplasms | 2.56e-04 | 59 | 12 | 2 | C0037286 | |
| Disease | Contact hypersensitivity | 3.71e-04 | 71 | 12 | 2 | C0162351 | |
| Disease | Contact Dermatitis | 3.71e-04 | 71 | 12 | 2 | C0011616 | |
| Disease | Squamous cell carcinoma | 1.12e-03 | 124 | 12 | 2 | C0007137 | |
| Disease | sphingomyelin measurement | 5.48e-03 | 278 | 12 | 2 | EFO_0010118 | |
| Disease | childhood onset asthma | 7.82e-03 | 334 | 12 | 2 | MONDO_0005405 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TADIHSYGSSGGGGS | 421 | Q9UMD9 | |
| GGTSGGSSGSFHYTF | 76 | O75953 | |
| SRASSSRSGGGGHGS | 616 | O00571 | |
| AYSSFGGGRGSRGSA | 11 | Q15056 | |
| SSSKHYSSSRSGGGG | 6 | P13645 | |
| GYGGGSSSGGHKSSS | 556 | P13645 | |
| SSSYGSGGRQSGSRG | 536 | P35908 | |
| AGGGRSSHGIRSSGT | 21 | P78368 | |
| EHGGSYARAGGSSRG | 6 | Q9BX97 | |
| SSRSGYRSGGGFSSG | 6 | P04264 | |
| AGSSSSYGQHGSGSR | 511 | Q86YZ3 | |
| GRSSSRGPYESGSGH | 566 | Q86YZ3 | |
| RGSGSGQSPSYGRHG | 896 | Q86YZ3 | |
| GQSPSYGRHGSGSGR | 901 | Q86YZ3 | |
| YGRHGSGSGRSSSSG | 906 | Q86YZ3 | |
| SGSGRSSSSGRHGSG | 911 | Q86YZ3 | |
| RGRHGSGSGQSSSYG | 1011 | Q86YZ3 | |
| YGRHGSGSGRSSSSG | 1141 | Q86YZ3 | |
| HGSGSGRSSSRGPYE | 1261 | Q86YZ3 | |
| YGHRGSGSSQSSGYG | 1336 | Q86YZ3 | |
| SGSSQSSGYGRHGAG | 1341 | Q86YZ3 | |
| SRGRHGSGSGHSSSY | 1361 | Q86YZ3 | |
| RGRHGSGSGQSSSYS | 1481 | Q86YZ3 | |
| YGRHGSGSGRSSSSG | 1611 | Q86YZ3 | |
| HGSGSGRSSSRGPYE | 1731 | Q86YZ3 | |
| SRGRHGSGSGHSSSY | 1831 | Q86YZ3 | |
| RGRHGSGSGQSSSYG | 1951 | Q86YZ3 | |
| YGRHGSGSGRSSSSG | 2081 | Q86YZ3 | |
| GERHGSSSGSSSRYG | 2146 | Q86YZ3 | |
| HGSGSGRSSSRGPYE | 2201 | Q86YZ3 | |
| SRGRHGSGSGHSSSY | 2301 | Q86YZ3 | |
| RGRHGSGSGQSSSYS | 2421 | Q86YZ3 | |
| YGRHGSGSGRSSSSG | 2551 | Q86YZ3 | |
| HGSGSGRSSSRGPYE | 2671 | Q86YZ3 | |
| YGHRGSGSSQSSGYG | 2746 | Q86YZ3 | |
| SGSSQSSGYGRHGAG | 2751 | Q86YZ3 | |
| GGGSSGGSSLESSRH | 626 | Q9BZ72 | |
| SGGGGYSSRRTSGRD | 86 | Q13247 | |
| SGGRSPDAYSGGHDS | 681 | Q8N7X1 |